Interferon-Based and Interferon-Free Regimens for Patients With Chronic Hepatitis C, Genotype 1: Potential Cost-Effectiveness of Biopsy-Guided Treatment Versus Treat All Strategies

被引：0
|
作者：
Younossi, Zobair M.
Singer, Mendel E.
Mir, Heshaam M.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S988 / S988
页数：1
相关论文
共 50 条
  • [1] All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
    Hagan, L. M.
    Yang, Z.
    Ehteshami, M.
    Schinazi, R. F.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (12) : 847 - 857
  • [2] Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C
    Grushko, Irina P.
    Romanova, Elena B.
    Tverdokhlebova, Tatiana I.
    Gapon, Marina N.
    Vodyanitskaya, Svetlana Yu.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (08) : 979 - 984
  • [3] Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
    Linas, Benjamin P.
    Morgan, Jake R.
    Pho, Mai T.
    Leff, Jared A.
    Schackman, Bruce R.
    Horsburgh, C. Robert
    Assoumou, Sabrina A.
    Salomon, Joshua A.
    Weinstein, Milton C.
    Freedberg, Kenneth A.
    Kim, Arthur Y.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [4] Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection
    Gray, E.
    O'Leary, A.
    Kieran, J. A.
    Fogarty, E.
    Dowling, T.
    Norris, S.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (09) : 677 - 686
  • [5] SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188)
    Deuffic-Burban, S.
    Schwarzinger, M.
    Obach, D.
    Mallet, V.
    Pol, S.
    Pageaux, G. -P.
    Canva, V.
    Deltenre, P.
    Roudot-Thoraval, F.
    Larrey, D.
    Dhumeaux, D.
    Mathurin, P.
    Yazdanpanah, Y.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S35 - S35
  • [6] Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study
    Jensen, Donald M.
    Brunda, Michael
    Elston, Robert
    Gane, Edward J.
    George, Jacob
    Glavini, Katerina
    Hammond, Janet M.
    Le Pogam, Sophie
    Najera, Isabel
    Passe, Sharon
    Piekarska, Anna
    Rodriguez, Ignacio
    Zeuzem, Stefan
    Chu, Tom
    LIVER INTERNATIONAL, 2016, 36 (04) : 505 - 514
  • [7] Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
    Younossi, Zobair M.
    Singer, Mendel E.
    Mir, Heshaam M.
    Henry, Linda
    Hunt, Sharon
    JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 530 - 537
  • [8] All-oral, interferon-free therapies for patients with chronic genotype 1 hepatitis C virus infection
    Siederdissen, C. Hoener Zu
    Cornberg, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (47) : 2411 - 2414
  • [9] THE IMPACT OF INTERFERON-FREE REGIMENS ON EMPLOYMENT RATE DURING TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C
    Kutala, B.
    Mourri, F.
    Boyer, N.
    Castelnau, C.
    Sitruk, V.
    Giuily, N.
    Asselah, T.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S662 - S663
  • [10] Access To Reimbursement Of Interferon-Free All-Oral Regimens For Patients With Chronic Hepatitis C In Austria
    Moser, Stephan
    Karpi, Asia
    Gutic, Enisa
    Schleicher, Michael
    Hellmich, Brigitte
    Gschwantler, Michael
    HEPATOLOGY, 2015, 62 : 1129A - 1129A
12345